BiOptix Diagnostics Garners $1,500,000 New Financing Round

  • Feed Type
  • Date
    2/27/2015
  • Company Name
    BiOptix Diagnostics
  • Mailing Address
    1775 38th St. Boulder, CO 80301 USA
  • Company Description
    The company’s mission is to develop its proprietary E-SPR (Enhanced Surface Plasmon Resonance) technology platform for the detection of molecular interactions.
  • Website
    http://www.bioptix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor